These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36267194)

  • 21. [Two Case of Rhino-Orbito-Cerebral Mucormicosis Developed After COVID-19 Infection].
    Demiroğu YZ; Ödemiş İ; Oruç E; Özer F; Ulaş B; Canpolat ET; Yalçın Ç; Öğüç Şanlı Ö
    Mikrobiyol Bul; 2021 Oct; 55(4):673-682. PubMed ID: 34666667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19-associated rhino-orbito-cerebral mucormycosis: a single center prospective study of 264 patients.
    Kim U; Perzia B; Kulkarni P; Rajiniganth M; Sundar B; Robin AL; Garg Shukla A; Maeng MM
    Orbit; 2024 Jul; ():1-10. PubMed ID: 39051497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
    Nair AG; Dave TV
    Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis.
    Singh P; Gupta A; Sanepalli SR; Raj A
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35361668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India.
    Rashbi K S; Ali TMF; P N D; C K S; Payyappilly RJ
    Access Microbiol; 2022 Aug; 4(6):acmi000360. PubMed ID: 36004359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhino-orbital-cerebral mucormycosis: fungal epidemic in a viral pandemic.
    Chouhan M; Solanki B; Shakrawal N
    J Laryngol Otol; 2021 Nov; 135(11):981-986. PubMed ID: 34470691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhino-Orbital Mucormycosis in a COVID-19 Patient: A Dreadful Challenge.
    Dhakal A; Pokharel M; Madhup S; Khadka L; Sapkota B
    Kathmandu Univ Med J (KUMJ); 2022; 20(78):249-251. PubMed ID: 37017177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
    Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
    Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-occurrence of rhino-orbital mucormycosis and acute lymphoblastic leukemia post-COVID-19 infection in a young adolescent male: A case report from a low middle-income country.
    Lingarapu M; Shaikh B; Singh A; Khan MA; Oduoye MO; Kamboj N; Danishwar M
    Clin Case Rep; 2024 Jun; 12(6):e8972. PubMed ID: 38799526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhino-orbital mucormycosis in a patient with acquired immunodeficiency syndrome (AIDS) and neutropenia.
    Hejny C; Kerrison JB; Newman NJ; Stone CM
    Am J Ophthalmol; 2001 Jul; 132(1):111-2. PubMed ID: 11438066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhino-orbital mucormycosis in a patient with no susceptibility following P.vivax malaria infection-a case report.
    Prasad S; Gaur A; Mehta A; Kaushal N
    BMC Ophthalmol; 2022 Oct; 22(1):389. PubMed ID: 36183076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucor in a Viral Land: A Tale of Two Pathogens.
    Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
    Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
    Songu M; Unlu HH; Gunhan K; Ilker SS; Nese N
    Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First report of rhino-orbital mucormycosis caused by
    Taghizadeh Armaki M; Jafarzadeh J; Mahdavi Omran S; Bayani M; Tavassoli A; Faeli L; Nosratabadi M; Yaalimadad S; Nikoueian B; Haghani I; Moazeni M; Shokohi T; Taghi Hedayati M; Abastabar M
    Curr Med Mycol; 2022 Jun; 8(2):49-54. PubMed ID: 36654791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhino-orbital Mucormycosis as a complication of severe COVID-19 pneumonia.
    Alamin MA; Abdulgayoom M; Niraula S; Abdelmahmuod E; Ahmed AO; Danjuma MI
    IDCases; 2021; 26():e01293. PubMed ID: 34603963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Kidney Injury Following Posaconazole for Mucormycosis: SARS-CoV-2 as a Back-Seat Driver.
    Noor M; Amin S; Rahim F; Ali B; Zafar S
    Cureus; 2022 Jul; 14(7):e27018. PubMed ID: 35989786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis.
    Murthy R; Bagchi A; Gote Y; Desai S
    Indian J Ophthalmol; 2022 Jan; 70(1):302-305. PubMed ID: 34937263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
    Liang KP; Tleyjeh IM; Wilson WR; Roberts GD; Temesgen Z
    J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of Rhino-Orbito-Cerebral Mucormycosis in Peru: Impact of the COVID-19 Pandemic.
    Cumpa-Quiroz R; Elguera-Falcón F; Guevara-Lazo DR
    Cureus; 2023 Sep; 15(9):e45240. PubMed ID: 37842460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.